114 related articles for article (PubMed ID: 30345496)
61. Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy.
Zapatero A; Martin De Vidales C; Arellano R; Ibañez Y; Bocardo G; Perez M; Rabadan M; García Vicente F; Cruz Conde JA; Olivier C
Urology; 2012 Nov; 80(5):1056-62. PubMed ID: 22999456
[TBL] [Abstract][Full Text] [Related]
62. [The effect of tri-modality therapy on the treatment of muscle-invasive bladder cancer].
Wang JF; Zhou XF; Fang DB; Wu ZM; Ding ZS; Chen X; Liu NB
Zhonghua Yi Xue Za Zhi; 2018 May; 98(20):1614-1616. PubMed ID: 29886656
[No Abstract] [Full Text] [Related]
63. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
[TBL] [Abstract][Full Text] [Related]
64. SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.
Leow JJ; Bedke J; Chamie K; Collins JW; Daneshmand S; Grivas P; Heidenreich A; Messing EM; Royce TJ; Sankin AI; Schoenberg MP; Shipley WU; Villers A; Efstathiou JA; Bellmunt J; Stenzl A
World J Urol; 2019 Jan; 37(1):61-83. PubMed ID: 30684034
[TBL] [Abstract][Full Text] [Related]
65. Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy.
Milenkovic U; Akand M; Moris L; Demaegd L; Muilwijk T; Bekhuis Y; Laenen A; Van Cleynenbreugel B; Everaerts W; Van Poppel H; Dumez H; Albersen M; Joniau S
World J Urol; 2019 Sep; 37(9):1857-1866. PubMed ID: 30519746
[TBL] [Abstract][Full Text] [Related]
66. Invasive bladder cancer in the eighties: transurethral resection or cystectomy?
Faba OR; Palou J; Urdaneta G; Gausa L; Villavicencio H
Int Braz J Urol; 2011; 37(1):49-55;discussion 55-6. PubMed ID: 21385480
[TBL] [Abstract][Full Text] [Related]
67. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
[TBL] [Abstract][Full Text] [Related]
68. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
69. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
70. Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer.
Martini T; Mayr R; Wehrberger C; Dechet C; Lodde M; Palermo S; Trenti E; Comploj E; Pycha A; Madersbacher S
Int Braz J Urol; 2013; 39(5):622-30. PubMed ID: 24267105
[TBL] [Abstract][Full Text] [Related]
71. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
72. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
Zhang M; Tao R; Zhang C; Shen Z
Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
[TBL] [Abstract][Full Text] [Related]
73. Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer.
Xia L; Taylor BL; Mamtani R; Christodouleas JP; Guzzo TJ
Urology; 2018 Apr; 114():87-94. PubMed ID: 29305205
[TBL] [Abstract][Full Text] [Related]
74. [Radical cystectomy in the treatment of bladder cancer always in due time?].
May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
[TBL] [Abstract][Full Text] [Related]
75. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of conservative approach in the management of ureteroenteric strictures following radical cystectomy with Bricker ileal conduit: a single-center experience.
Baten E; Akand M; Floyd MS; Van Cleynenbreugel B; Albersen M; Everaerts W; Van Poppel H; Van Der Aa F; Joniau S
Scand J Urol; 2016 Dec; 50(6):439-444. PubMed ID: 27686879
[TBL] [Abstract][Full Text] [Related]
77. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
Patel MI; Bang A; Gillatt D; Smith DP
BJU Int; 2015 Oct; 116 Suppl 3():18-25. PubMed ID: 26334934
[TBL] [Abstract][Full Text] [Related]
78. Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients.
Koga F; Numao N; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
Urol Oncol; 2013 Oct; 31(7):1270-5. PubMed ID: 22386622
[TBL] [Abstract][Full Text] [Related]
79. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
80. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
